Agoracom Blog Home

Author Archive

POET Technologies $PTK.ca $POETF Provides Highlights and Results of Special Meeting

Posted by AGORACOM-JC at 10:35 AM on Monday, February 22nd, 2021
  • Announces the results of the Special Meeting (the “Meeting”) held virtually on Friday February 19, 2021.
  • Authorization from the Company’s shareholders to enable the Board of Directors, within its sole discretion, to consolidate the Company’s issued and outstanding common shares on the basis of one post-consolidation common share for a number of pre-consolidation common shares ranging between two (2) and fourteen (14) as outlined in the Company’s management information circular and voting material sent to the shareholders.

TORONTO, Feb. 22, 2021 – POET Technologies Inc. (“ POET ” or the “ Company ”) (TSX Venture: PTK; OTCQX: POETF), the designer and developer of the POET Optical Interposer™ and Photonic Integrated Circuits (PICs) for the data center and tele-communication markets announces the results of the Special Meeting (the “Meeting”) held virtually on Friday February 19, 2021.

The Company’s Chairman and Chief Executive Officer, Dr. Suresh Venkatesan, conducted the formal business of the Meeting, which focused solely on seeking authorization from the Company’s shareholders to enable the Board of Directors, within its sole discretion, to consolidate the Company’s issued and outstanding common shares on the basis of one post-consolidation common share for a number of pre-consolidation common shares ranging between two (2) and fourteen (14) as outlined in the Company’s management information circular and voting material sent to the shareholders.

Read More: https://agoracom.com/ir/POETTechnologies/forums/discussion/topics/755798-poet-technologies-provides-highlights-and-results-of-special-meeting/messages/2304711#message

Kontrol $KNR $KNR.ca $KNR.c $KNRLF Establishes Scientific Advisory Board for BioCloud Technology $SNE $MSFT $HON $GOOGL $QCOM

Posted by AGORACOM-JC at 10:21 AM on Monday, February 22nd, 2021
  • Announce that it has established its previously announced scientific advisory board, (see press release dated January 20th, 2021) to assist the Company to accelerate existing applications and to develop new BioCloud technology applications.
  • “Now more than ever viral detection technology is critical to getting the economy and everyday life back to normal,” says Paul Ghezzi, CEO of Kontrol.

TORONTO, ON / February 22, 2021 / Kontrol Technologies Corp. (CSE:KNR)(OTCQB:KNRLF)(FSE:1K8) (“Kontrol Technologies” or “Kontrol” or “Company“) is pleased to announce that it has established its previously announced scientific advisory board, (see press release dated January 20th, 2021) to assist the Company to accelerate existing applications and to develop new BioCloud technology applications.

“Now more than ever viral detection technology is critical to getting the economy and everyday life back to normal,” says Paul Ghezzi, CEO of Kontrol. “Vaccines are integral to a broader recovery, however more technology is required for detection and monitoring. We are pleased to be taking a leadership role in this new industry of real-time viral detection infrastructure. Our technology was developed for the current pandemic and the pandemics of the future.”

“We are very pleased to establish a world class advisory board for Kontrol BioCloud,” says Gary Saunders, VP Kontrol. “Our advisory board members are at the top of their field and their counsel will be very important to the future of Kontrol BioCloud and other innovative applications of the technology we may seek to develop.”

Read More: https://agoracom.com/ir/KontrolTechnologies/forums/discussion/topics/755793-kontrol-establishes-scientific-advisory-board-for-biocloud-technology/messages/2304704#message

Else Nutrition $BABY.ca $BABYF has Developed a Breakthrough, Patent-Pending Clean Processing of Ingredients for its Infant Formula $VERY.ca $MEAT.ca $EATS.ca $VEGN.ca

Posted by AGORACOM-JC at 9:53 AM on Monday, February 22nd, 2021
http://blog.agoracom.com/wp-content/uploads/2020/03/else-square-150x150.png
  • Else has developed a breakthrough, proprietary process to further ensure the safety of the formula.
  • This patent pending process will contribute greatly to Else’s realization of an infant formula in worldwide markets and provide higher standards of safety, health and natural nutrition for babies, toddlers and children.

VANCOUVER, BC , Feb. 22, 2021 – ELSE NUTRITION HOLDINGS INC. (TSXV: BABY) (OTCQX: BABYF) (FSE: 0YL) (“Else” or the “Company”) the plant-based baby, toddler and children nutrition company , announces as part of its progress towards commercializing a clean label, dairy-free and soy-free, plant-based infant formula, Else has developed a breakthrough, proprietary process to further ensure the safety of the formula. This patent pending process will contribute greatly to Else’s realization of an infant formula in worldwide markets and provide higher standards of safety, health and natural nutrition for babies, toddlers and children.

This new process builds on the company’s already clean and most natural production process that ensures the highest quality standards – it does not use harsh chemicals or detergents (commonly used in the industry) and does not impact the formula’s amino acids or other macronutrients.

“The World Health Organization considers the first 1000 days of life as critically important to long term health and wellness. It’s the window of time where optimum brain and immune system development is established. Infant formula is the exclusive form of nourishment for many babies during this critical period of development. The recent consumer and regulatory call to action is especially prudent to the formula category. Else Nutrition is voluntarily and proactively changing the way they source ingredients, manufacture their products, and think about food safety all in an effort to optimize environmental and public health now and into the future,” said Jaclyn Bowen MPH, MS food and consumer products safety and systems engineer and Executive Director of Clean Label Project.

“We’re leading a clean revolution, disrupting the baby food industry by setting a new standard in quality, transparency and sustainability. This latest development brings us even closer to bringing clean label, plant-based, minimally processed infant formula to wanting parents worldwide,” said Hamutal Yitzhak , CEO and Co-Founder of Else Nutrition.

The novel pre-process was under development for nearly a year. A full Pilot stage was successfully completed and tested recently at the company’s innovation center in Northern Israel , positively demonstrating reduction of specific elements levels.

Already a recipient of The Clean Label Project’s Purity Award (an honor only bestowed after products are tested for over 400 contaminants and heavy metals and meet the organization’s highest standard) for its Plant-Based Complete Nutrition for Toddlers product, Else continues its commitment to ‘cleaning up’ the baby/toddler nutrition aisles with safe, clean label products of the highest quality.

Else is proud to share this exciting development and its continued commitment to baby food safety and quality, in light of a recent congressional report that revealed that many baby food products offered by leading manufacturers contain significant levels of toxic heavy metals.

Else’s ‘Beyond Organic’ Processing

Else Nutrition is primarily made of almonds, tapioca and buckwheat; three core ingredients that go through a clean, all-natural process that provides the protein, carbohydrates, and fat directly from the whole plants, along with phytonutrients, fiber, vitamins and minerals nature intended to provide optimal nourishment for children. Else is free of dairy, soy and corn-syrup, and is made with non-GMO ingredients. It is made using a clean, most natural and sustainable industry process.

Read More: https://agoracom.com/ir/ElseNutritionHoldings/forums/discussion/topics/755787-else-nutrition-has-developed-a-breakthrough-patent-pending-clean-processing-of-ingredients-for-its-infant-formula/messages/2304698#message

ThreeD Capital Inc. $IDK $IDKFF Announces DTC Eligibility of its Common Shares Trading in the United States $INTL.ca $IP.ca $IPNFF $PKK.ca $PKKFF $MTRX $RACMF

Posted by AGORACOM-JC at 9:45 AM on Monday, February 22nd, 2021
IDK-square-for-blog
  • Now eligible for electronic clearing and settlement through the Depository Trust Company (“DTC”) in the United States.
  • The Company’s common shares are traded on the OTCQB under the symbol “IDKFF”.

TORONTO, Feb. 22, 2021 — ThreeD Capital Inc. (the “Company” or “ThreeD”) (CSE:IDK) (OTCQB:IDKFF) is pleased to announce that the Company’s common shares are now eligible for electronic clearing and settlement through the Depository Trust Company (“DTC”) in the United States. The Company’s common shares are traded on the OTCQB under the symbol “IDKFF”.

DTC is a subsidiary of the Depository Trust and Clearing Corporation, a United States company that manages the electronic clearing and settlement of publicly traded companies. DTC services reduces costs and accelerates the settlement process for investors and brokers trading Canadian securities in the United States.

Sheldon Inwentash, CEO of ThreeD commented, “We are thrilled with obtaining DTC eligibility, as it represents an important step forward in increasing liquidity, broadening our shareholder base and building a strong presence for the Company within the US capital markets sphere.”

About ThreeD Capital Inc.

ThreeD is a publicly-traded Canadian-based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors. ThreeD’s investment strategy is to invest in multiple private and public companies across a variety of sectors globally. ThreeD seeks to invest in early stage, promising companies where it may be the lead investor and can additionally provide investees with advisory services and access to the Company’s ecosystem.

For further information:

Jakson Inwentash
Vice President Investments
[email protected]
Phone: 416-941-8900 ext 107

The Canadian Securities Exchange has neither approved nor disapproved the contents of this news release and accepts no responsibility for the adequacy or accuracy hereof.

Read More: https://agoracom.com/ir/threedcapital/forums/discussion/topics/755784-threed-capital-inc-announces-dtc-eligibility-of-its-common-shares-trading-in-the-united-states/messages/2304695#message

VIDEO – VSBLTY Groupe $VSBY.ca $VSBGF Is Ramping Up in the Digital Display Space, with Three Major Deals in the Past Two Weeks $MARK $AT

Posted by AGORACOM-JC at 8:00 PM on Sunday, February 21st, 2021

Earlier this month we told you about VSBLTY Groupe Technologies (VSBY:CSE) (VSBGF:US), a disruptive computer vision software company that is using A.I. and Machine Learning to transform the retail and security industries. 

  • $VSBY Teaches Computers How to Interpret Surroundings. For example, detecting anomalies better than any human ever can
  • $VSBY Then Delivers the Context of Their Surroundings via Alerts, so that humans can make decisions and act on then faster than ever possible
  • $VSBY technology serves the dual function of both monitoring (i.e. a stadium, a store) and marketing (serving ads based on real-time demographics)

Since that first video, VSBLTY has issued three separate, major news releases:

  • On Feb 4, it partnered with 911inform on a deal to improve emergency response, safety & security in schools, hospitals & offices
  • On Feb 9, it unveiled a partnership with Ability Enterprise Co., which will see cutting-edge cameras integrated into a new media network of up to 10,000 convenience stores in Latin America.
  • On Feb 16, it penned a partnership with EOS Linx to provide a solar-powered security solution utilizing ai-driven proprietary software.

We sat down with Jay Hutton, VSBLTY’s co-founder, CEO and President, to break down the firm’s rapid expansion:

VIDEO – ThreeD Capital $IDK $IDKFF First Monthly NAV Is Just The Beginning Of Exponentially Growing Portfolio $INTL.ca $CRL.ca $WUHN

Posted by AGORACOM-JC at 7:53 PM on Sunday, February 21st, 2021
IDK-square-for-blog

VIDEO – Valeo Pharma $VPH $VPHIF Hesperco Capsules at Core of Montreal Heart Institute’s Coronavirus Clinical Trial $HLS.ca $MDP.ca $GUD.ca $RX.ca

Posted by AGORACOM-JC at 7:38 PM on Sunday, February 21st, 2021
Valeo Pharma (@valeo_pharma) | Twitter

VIDEO – ORTHO Regenerative Technologies $ORTH.ca $ORTIF is Using Proprietary Tech to Improve Surgery Success Rates and Seize a $5bn Market Opportunity

Posted by AGORACOM-JC at 7:17 PM on Sunday, February 21st, 2021

ORTHO Regenerative Technologies is a cutting-edge med tech firm that uses its proprietary RESTORE technology platform to dramatically improve the success rate of orthopedic and sports medicine surgeries.

  • In layman’s terms, that means company has a wonder delivery platform that delivers biologics – drugs made from biological processes – to repair soft tissues in the human body.

The technology uses biologics derived from things like plasma and bone marrow concentrate to regenerate new tissue in various musculoskeletal conditions.

  • This includes Wound Healing, Cartilage repair and Osteo-arthritis

So, how big is the market opportunity for Soft Tissue Repair? At least $5bn in the U.S. alone. This includes:

Rotator Cuff TEAR (which leads to shoulder dysfunction and pain):

  • 4m patients in the U.S. alone
  • 600,000 annual surgeries in the U.S. alone
  • $600m+ market opportunity

Meniscus Tear Repair (which is painful and compromises knee function):

  • There are 1.2m surgeries annually in U.S. alone
  • $1bn+ market opportunity

Cartilage Lesions Repair (this is where lesions cause friction and pain):

  • 1.2m detected lesions annually in U.S. alone
  • 120,000 surgeries and a lack of options
  • $1bn+ market opportunity

Get comfy for this insightful interview with Claude LeDuc, Ortho’s CEO.

California Grants #Cannabis Cultivation License to TransCanna $TCAN.ca $VFF.ca $ACB.ca $GTII.ca $TEQ.ca

Posted by AGORACOM-JC at 3:24 PM on Saturday, February 20th, 2021
tcan-square

Game-changing achievement for the budding cannabis enterprise

  • Received a highly coveted cultivation license from the State of California that will accelerate the Company’s cultivation capacity almost immediately
  • license represents a major milestone achievement in its endeavors to be California’s leading fully integrated cannabis cultivator, processor, manufacturer, wholesaler and distributor
  • “Obtaining this license is a significant turning point for TransCanna and opens up the door to the explosive growth we’ve been positioning ourselves for,” said Bob Blink

Vancouver, British Columbia–(February 20, 2021) –  TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (“TransCanna” or the “Company”) is pleased to announce that it has received a highly coveted cultivation license from the State of California that will accelerate the Company’s cultivation capacity almost immediately.

The State of California has granted a cultivation license to Lyfted Farms – a TransCanna wholly owned subsidiary – for its flagship Daly facility in Modesto, California. Bob Blink, TransCanna CEO states “Such cultivation licenses in the region are notoriously difficult to obtain. Current applications are back-logged and not even being considered for processing by the county until the end of 2021.”

For TransCanna, the license represents a major milestone achievement in its endeavors to be California’s leading fully integrated cannabis cultivator, processor, manufacturer, wholesaler and distributor.

“Obtaining this license is a significant turning point for TransCanna and opens up the door to the explosive growth we’ve been positioning ourselves for,” said Bob Blink. “Demand has been consistently outstripping supply for our exotic indoor cannabis strains, and now with this new massive facility receiving approval for cultivation, we can finally meet that demand and continue to scale. This will make us one of the largest licensed facilities of its kind in the State of California.”

In addition to cultivation, the new Daly facility empowers TransCanna to increase its scope of offerings and establish its dominance in the California cannabis supply chain.

The Daly facility will anchor other TransCanna operations and serve as a supply chain hub for third party farms across Northern California, offering secure storage, concentrate manufacturing, wholesale market-making, white label services, and State-wide distribution.

Prior to achieving its cultivation license, the facility gained its distribution license in June 2020. Next, TransCanna is eagerly anticipating its processing license (pending approval by the State of California mid to late March) which will qualify the company to dry, cure, trim, grade, and package cannabis onsite. In addition to saving time and money for in-house brands with on-site processing, the processing license will enable TransCanna to open up new revenue streams servicing third party growers.

“California’s cannabis market is $5 billion in sales and growing, and we are well on our way to establishing ourselves at the epicenter of this category with our cultivation, processing, wholesaling and distribution arms of the entire California supply chain,” said Bob Blink, TransCanna CEO.

About TransCanna

TransCanna Holdings Inc. is a California-based, Canadian-listed company building cannabis-focused brands for the California lifestyle, through its wholly-owned California subsidiaries.

TransCanna’s wholly owned subsidiary Lyfted Farms is California’s authentic cannabis brand whose pioneering spirit has been continuously providing the finest cannabis flower genetics and cultivation methods since 1984. The Lyfted Farms brand of exclusive cannabis flower is sold at premium retailers throughout the state. With its new cultivation facility in Daly, California, the company is now poised to become one of the largest and most efficient vertically integrated cannabis companies in the California market.

Read more: https://agoracom.com/ir/TranscannaHoldings/forums/discussion/topics/755740-california-grants-cannabis-cultivation-license-to-transcanna/messages/2304595#message

@Novamind_Inc $NM.ca $NVMDF Weekly Roundup $RVV.ca $MMED $PSYC.ca $FTRP.ca $CMPS $NUMI.ca

Posted by AGORACOM-JC at 9:54 AM on Saturday, February 20th, 2021

A weekly summary of Novamind news and media

FEATURES February 19, 2021

Dr. Reid Robison on Our Purpose-Driven Mission to Help People who are Suffering

Agoracom interviewed our Chief Medical Officer about our latest expansions, the striking results from treatments, and what it takes to build infrastructure for psychedelic-assisted healthcare.

FEATURES February 18, 2021

Novamind Leading the Charge to Deliver Mental Health Alternatives

Psychedelic Invest published an article about the urgent need for innovative mental health treatments, and the companies working to meet that need.

View all media

Novamind Announces Symbol Change on OTC Market To “NVMDF”

February 19, 2021

View all press releases

Follow @novamind_inc on Instagram

Novamind is a leading mental health company enabling safe access to psychedelic medicine through a network of clinics, retreats, and clinical research sites. Novamind provides ketamine-assisted psychotherapy and other novel treatments through its network of Cedar Psychiatry clinics and operates Cedar Clinical Research, a contract research organization specialized in clinical trials and evidence-based research for psychedelic medicine. Both Cedar Psychiatry and Cedar Clinical Research are wholly-owned subsidiaries of Novamind. For more information on how Novamind is enhancing mental wellness and guiding people through their entire healing journey, visit www.novamind.ca